The carboxypeptidase ACE2 is a homologue of angiotensin-converting enzyme (ACE). To clarify the physiological roles of ACE2, we generated mice with targeted disruption of the Ace2 gene. ACE2-deficient mice were viable, fertile, and lacked any gross structural abnormalities. We found normal cardiac dimensions and function in ACE2-deficient animals with mixed or inbred genetic backgrounds. On the C57BL/6 background, ACE2 deficiency was associated with a modest increase in blood pressure, whereas the absence of ACE2 had no effect on baseline blood pressures in 129/SvEv mice. After acute Ang II infusion, plasma concentrations of Ang II increased almost 3-fold higher in ACE2-deficient mice than in controls. In a model of Ang II–dependent hypertension, blood pressures were substantially higher in the ACE2-deficient mice than in WT. Severe hypertension in ACE2-deficient mice was associated with exaggerated accumulation of Ang II in the kidney, as determined by MALDI-TOF mass spectrometry. Although the absence of functional ACE2 causes enhanced susceptibility to Ang II–induced hypertension, we found no evidence for a role of ACE2 in the regulation of cardiac structure or function. Our data suggest that ACE2 is a functional component of the renin-angiotensin system, metabolizing Ang II and thereby contributing to regulation of blood pressure.
Susan B. Gurley, Alicia Allred, Thu H. Le, Robert Griffiths, Lan Mao, Nisha Philip, Timothy A. Haystead, Mary Donoghue, Roger E. Breitbart, Susan L. Acton, Howard A. Rockman, Thomas M. Coffman
Title and authors | Publication | Year |
---|---|---|
Elevated Arterial Blood Pressure as a Delayed Complication Following COVID-19—A Narrative Review
Bielecka E, Sielatycki P, Pietraszko P, Zapora-Kurel A, Zbroch E |
International journal of molecular sciences | 2024 |
ACE2 alleviates sepsis-induced cardiomyopathy through inhibiting M1 macrophage via NF-κB/STAT1 signals
Xiao X, Li JX, Li HH, Teng F |
Cell Biology and Toxicology | 2024 |
Tight junction protein LSR is a host defense factor against SARS-CoV-2 infection in the small intestine.
An Y, Wang C, Wang Z, Kong F, Liu H, Jiang M, Liu T, Zhang S, Du K, Yin L, Jiao P, Li Y, Fan B, Zhou C, Wang M, Sun H, Lei J, Zhao S, Gong Y |
The EMBO journal | 2024 |
Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population
Frasca L, Ocone G, Palazzo R |
Pathogens | 2023 |
Dietary carotenoids to improve hypertension
Abbasian F, Alavi MS, Roohbakhsh A |
Heliyon | 2023 |
USP2 inhibition prevents infection with ACE2-dependent coronaviruses in vitro and is protective against SARS-CoV-2 in mice
Dang F, Bai L, Dong J, Hu X, Wang J, Paulo JA, Xiong Y, Liang X, Sun Y, Chen Y, Guo M, Wang X, Huang Z, Inuzuka H, Chen L, Chu C, Liu J, Zhang T, Rezaeian AH, Liu J, Kaniskan HÜ, Zhong B, Zhang J, Letko M, Jin J, Lan K, Wei W |
Science Translational Medicine | 2023 |
Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2.
Friedrich M, Pfeifer G, Binder S, Aigner A, Vollmer Barbosa P, Makert GR, Fertey J, Ulbert S, Bodem J, König EM, Geiger N, Schambach A, Schilling E, Buschmann T, Hauschildt S, Koehl U, Sewald K |
Frontiers in Bioengineering and Biotechnology | 2022 |
The Effect of FGF23 on Cardiac Hypertrophy Is Not Mediated by Systemic Renin-Angiotensin- Aldosterone System in Hemodialysis
Dörr K, Kammer M, Reindl-Schwaighofer R, Lorenz M, Marculescu R, Poglitsch M, Beitzke D, Oberbauer R |
Frontiers in Medicine | 2022 |
Insights into Cardiovascular Defects and Cardiac Epigenome in the Context of COVID-19
Sarkar S, Sen R |
Epigenomes | 2022 |
Walnut supplementation after fructose-rich diet is associated with a beneficial fatty acid ratio and increased ACE2 expression in the rat heart
Bošković M, Živković M, Koricanac G, Tepavcevic S, Zec M, Debeljak-Martacic J, Stanković A |
Frontiers in physiology | 2022 |
Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting
Lin H, Geurts F, Hassler L, Batlle D, Mirabito Colafella KM, Denton KM, Zhuo JL, Li XC, Ramkumar N, Koizumi M, Matsusaka T, Nishiyama A, Hoogduijn MJ, Hoorn EJ, Danser AH |
Pharmacological reviews | 2022 |
Impact of the Renin-Angiotensin System on the Pathogeny and Pharmacotherapeutics of Neurodegenerative Diseases.
Bild W, Vasincu A, Rusu RN, Ababei DC, Stana AB, Stanciu GD, Savu B, Bild V |
Biomolecules | 2022 |
Soluble ACE2 Is Filtered into the Urine
Nelson JW, Ortiz-Melo DI, Mattocks NK, Emathinger JM, Prescott J, Xu K, Griffiths RC, Wakasaki R, Piehowski PD, Hutchens MP, Coffman TM, Gurley SB |
2022 | |
The role of SARS‐CoV‐2 target ACE2 in cardiovascular diseases
H Zhu, L Zhang, Y Ma, M Zhai, L Xia, J Liu, S Yu, W Duan |
Journal of Cellular and Molecular Medicine | 2021 |
SARS CoV2 infection _The longevity study perspectives
D Lio, L Scola, RM Giarratana, G Candore, G Colonna-Romano, C Caruso, CR Balistreri |
Ageing Research Reviews | 2021 |
Mechanical Stretch Induces Smooth Muscle Cell Dysfunction by Regulating ACE2 via P38/ATF3 and Post-transcriptional Regulation by miR-421
X Liu, X Liu, M Li, Y Zhang, W Chen, M Zhang, C Zhang, M Zhang |
Frontiers in physiology | 2021 |
Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications
A Kianmehr, I Faraoni, O Kucuk, A Mahrooz |
European Journal of Clinical Microbiology & Infectious Diseases | 2021 |
Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis?
SM Gonzalez, AB Siddik, RC Su |
Frontiers in immunology | 2021 |
New perspectives on angiotensin-converting enzyme 2 and its related diseases
LP Liu, XL Zhang, J Li |
World journal of diabetes | 2021 |
Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases
RK Sharma, J Li, S Krishnan, EM Richards, MK Raizada, R Mohandas |
Clinical Science | 2021 |
Challenge of post-COVID era: management of cardiovascular complications in asymptomatic carriers of SARS-CoV-2
S Gupta, A Mitra |
Heart Failure Reviews | 2021 |
Renal Manifestations of Covid-19: Physiology and Pathophysiology
Z Armaly, S Kinaneh, K Skorecki |
Journal of Clinical Medicine | 2021 |
Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients
M Fagyas, V Bánhegyi, K Úri, A Enyedi, E Lizanecz, IS Mányiné, L Mártha, GÁ Fülöp, T Radovits, M Pólos, B Merkely, Á Kovács, Z Szilvássy, Z Ungvári, I Édes, Z Csanádi, J Boczán, I Takács, G Szabó, J Balla, G Balla, P Seferovic, Z Papp, A Tóth |
GeroScience | 2021 |
Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis
S Seeherman, YJ Suzuki |
International journal of molecular sciences | 2021 |
Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
Y Hu, L Liu, X Lu |
Frontiers in Endocrinology | 2021 |
COVID-19 and male reproductive system: pathogenic features and possible mechanisms
AA Zadeh, D Arab |
Journal Of Molecular Histology | 2021 |
Renin–angiotensin system blockade in the COVID-19 pandemic
JB Cohen, AM South, HA Shaltout, MR Sinclair, MA Sparks |
Clinical Kidney Journal | 2021 |
Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies
WH Faour, A Choaib, E Issa, FE Choueiry, K Shbaklo, M Alhajj, RT Sawaya, Z Harhous, E Alefishat, M Nader |
Inflammation Research | 2021 |
Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
RM Touyz, MO Boyd, T Guzik, S Padmanabhan, L McCallum, C Delles, PB Mark, JR Petrie, F Rios, AC Montezano, R Sykes, C Berry |
2021 | |
COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases
Y Zhang, M Wang, X Zhang, T Liu, P Libby, GP Shi |
2021 | |
Advances in use of mouse models to study the renin-angiotensin system
J Emathinger, J Nelson, S Gurley |
Molecular and Cellular Endocrinology | 2021 |
Evolutionary pathways to SARS-CoV-2 resistance are opened and closed by epistasis acting on ACE2.
Castiglione GM, Zhou L, Xu Z, Neiman Z, Hung CF, Duh EJ |
PLoS Biology | 2021 |
Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19
Rajtik T, Galis P, Bartosova L, Paulis L, Goncalvesova E, Klimas J |
International journal of molecular sciences | 2021 |
The Mechanism of High-Output Cardiac Hypertrophy Arising From Potassium Channel Gain-of-Function in Cantú Syndrome
C McClenaghan, Y Huang, SJ Matkovich, A Kovacs, CJ Weinheimer, R Perez, TJ Broekelmann, TM Harter, JM Lee, MS Remedi, CG Nichols |
Function | 2020 |
ACE2 mouse models: a toolbox for cardiovascular and pulmonary research
H Jia, X Yue, E Lazartigues |
Nature Communications | 2020 |
Sex-Specific Modulation of Blood Pressure and the Renin-Angiotensin System by ACE (Angiotensin-Converting Enzyme) 2
H Ji, AM de Souza, B Bajaj, W Zheng, X Wu, RC Speth, K Sandberg |
Hypertension | 2020 |
Biological Context Linking Hypertension and Higher Risk for COVID-19 Severity
CA Tavares, MA Bailey, AC Girardi |
Frontiers in physiology | 2020 |
Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System
A Brojakowska, J Narula, R Shimony, J Bander |
Journal of the American College of Cardiology | 2020 |
The ACE2‐deficient mouse: A model for a cytokine storm‐driven inflammation
J Wang, N Kaplan, J Wysocki, W Yang, K Lu, H Peng, D Batlle, RM Lavker |
The FASEB Journal | 2020 |
Recent updates on COVID-19: A holistic review
S Jakhmola, O Indari, D Kashyap, N Varshney, A Rani, C Sonkar, B Baral, S Chatterjee, A Das, R Kumar, HC Jha |
Heliyon | 2020 |
Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2)
O Wiese, AE Zemlin, TS Pillay |
Journal of clinical pathology | 2020 |
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices
MA Sparks, AM South, AD Badley, CM Baker-Smith, D Batlle, B Bozkurt, R Cattaneo, SD Crowley, LJ DellItalia, AL Ford, K Griendling, SB Gurley, SE Kasner, JA Murray, KA Nath, MA Pfeffer, J Rangaswami, WR Taylor, VD Garovic |
Hypertension | 2020 |
ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
F Saponaro, G Rutigliano, S Sestito, L Bandini, B Storti, R Bizzarri, R Zucchi |
Frontiers in Molecular Biosciences | 2020 |
Implications of renal ACE2 expression in the age of COVID-19
HM Salah, JM Arthur, JL Mehta |
European Heart Journal | 2020 |
Angiotensin-converting enzyme 2 influences pancreatic and renal function in diabetic mice
H Roca-Ho, V Palau, J Gimeno, J Pascual, MJ Soler, M Riera |
Laboratory Investigation | 2020 |
COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
R Amraei, N Rahimi |
Cells | 2020 |
Cardiovascular Changes in Patients With COVID-19 From Wuhan, China
L Song, S Zhao, L Wang, K Yang, W Xiao, SP Clifford, J Huang, X Chen |
Frontiers in Cardiovascular Medicine | 2020 |
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2
RK Sharma, BR Stevens, AG Obukhov, MB Grant, GY Oudit, Q Li, EM Richards, CJ Pepine, MK Raizada |
Hypertension | 2020 |
Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications
N Banu, SS Panikar, LR Leal, AR Leal |
Life Sciences | 2020 |
Identifying pathophysiological bases of disease in COVID-19
CJ Goldin, R Vázquez, FP Polack, D Alvarez-Paggi |
Translational Medicine Communications | 2020 |
Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection
S de Maat, Q de Mast, AH Danser, FL van de Veerdonk, C Maas |
Seminars in thrombosis and hemostasis | 2020 |
Covid‐19, ACE2 and the kidney
JH Hardenberg, FC Luft |
Acta physiologica (Oxford, England) | 2020 |
The Genetic Dissection of Ace2 Expression Variation in the Heart of Murine Genetic Reference Population
F Xu, J Gao, U Munkhsaikhan, N Li, Q Gu, JF Pierre, A Starlard-Davenport, JA Towbin, Y Cui, E Purevjav, L Lu |
Frontiers in Cardiovascular Medicine | 2020 |
COVID-19 and RAS: Unravelling an Unclear Relationship
D DArdes, A Boccatonda, I Rossi, MT Guagnano, F Santilli, F Cipollone, M Bucci |
International journal of molecular sciences | 2020 |
Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice
J Stegbauer, SE Thatcher, G Yang, K Bottermann, LC Rump, A Daugherty, LA Cassis |
Journal of Vascular Surgery | 2019 |
Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling
T Sato, A Kadowaki, T Suzuki, H Ito, H Watanabe, Y Imai, K Kuba |
International journal of molecular sciences | 2019 |
Angiotensin-(1-7) inhibits sodium transport via Mas receptor by increasing nitric oxide production in thick ascending limb
P Dibo, RO Marañón, K Chandrashekar, F Mazzuferi, GB Silva, LA Juncos, LI Juncos |
Physiological Reports | 2019 |
Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD)
K Dörr, M Kammer, R Reindl-Schwaighofer, M Lorenz, C Loewe, R Marculescu, R Erben, R Oberbauer |
Trials | 2019 |
Novel Variants of Angiotensin Converting Enzyme-2 of Shorter Molecular Size to Target the Kidney Renin Angiotensin System
J Wysocki, A Schulze, D Batlle |
Biomolecules | 2019 |
Different effects of the deletion of angiotensin converting enzyme 2 and chronic activation of the renin-angiotensin system on muscle weakness in middle-aged mice
H Takeshita, K Yamamoto, M Mogi, S Nozato, M Horiuchi, H Rakugi |
Hypertension Research | 2019 |
Genetic Models
Alenina N, Bader M |
2019 | |
ATAC-ing the Mechanisms of Renin Regulation
Steven Crowley |
Journal of Clinical Investigation | 2018 |
The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
RA Santos, WO Sampaio, AC Alzamora, D Motta-Santos, N Alenina, M Bader, MJ Campagnole-Santos |
Physiological reviews | 2018 |
ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models
N Alenina, M Bader |
Neurochemical Research | 2018 |
The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases
XC Li, J Zhang, JL Zhuo |
Pharmacological Research | 2017 |
Macrophages in neuroinflammation: role of the renin-angiotensin-system
A Hammer, J Stegbauer, RA Linker |
Pflügers Archiv - European Journal of Physiology | 2017 |
Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II
C Maier, I Schadock, PK Haber, J Wysocki, M Ye, Y Kanwar, CA Flask, X Yu, BD Hoit, GN Adams, AH Schmaier, M Bader, D Batlle |
Journal of Molecular Medicine | 2017 |
Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors
YY Chen, D Liu, P Zhang, JC Zhong, CJ Zhang, SL Wu, YQ Zhang, GZ Liu, M He, LJ Jin, HM Yu |
Journal of Human Hypertension | 2016 |
Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney
O Domenig, A Manzel, N Grobe, E Königshausen, CC Kaltenecker, JJ Kovarik, J Stegbauer, SB Gurley, D Oyen, M Antlanger, M Bader, D Motta-Santos, RA Santos, KM Elased, MD Säemann, RA Linker, M Poglitsch |
Scientific Reports | 2016 |
Interventional procedures and future drug therapy for hypertension
MD Lobo, PA Sobotka, A Pathak |
European Heart Journal | 2016 |
Effects of ACE2 deficiency on physical performance and physiological adaptations of cardiac and skeletal muscle to exercise
D Motta-Santos, RA Santos, M Oliveira, F Qadri, M Poglitsch, V Mosienko, LK Becker, MJ Campagnole-Santos, JM Penninger, N Alenina, M Bader |
Hypertension Research | 2016 |
Genetic Deletion of ACE2 Induces Vascular Dysfunction in C57BL/6 Mice: Role of Nitric Oxide Imbalance and Oxidative Stress
LA Rabelo, M Todiras, V Nunes-Souza, F Qadri, IA Szijártó, M Gollasch, JM Penninger, M Bader, RA Santos, N Alenina, HH Schmidt |
PloS one | 2016 |
Chymase-dependent production of angiotensin II: an old enzyme in old hearts
G Froogh, JT Pinto, Y Le, S Kandhi, Y Aleligne, A Huang, D Sun |
American journal of physiology. Heart and circulatory physiology | 2016 |
High-fat diet-induced glucose dysregulation is independent of changes in islet ACE2 in mice
H Chodavarapu, KH Chhabra, H Xia, V Shenoy, X Yue, E Lazartigues |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2016 |
FGF23 from bench to bedside
CP Kovesdy, LD Quarles |
American journal of physiology. Renal physiology | 2016 |
Loss of Prolyl Carboxypeptidase in Two-Kidney, One-Clip Goldblatt Hypertensive Mice
N Grobe, O Leiva, M Morris, KM Elased, S Fuchs |
PloS one | 2015 |
ACE and ACE2 in kidney disease
S Mizuiri |
World Journal of Nephrology | 2015 |
Plasma and Kidney Angiotensin Peptides: Importance of the Aminopeptidase A/Angiotensin III Axis
J Wysocki, M Ye, D Batlle |
American Journal of Hypertension | 2015 |
Animal Models with a Genetic Alteration of the ACE2/Ang-(1-7)/Mas Axis
Rabelo LA, Nunes-Souza V, Bader M |
The Protective Arm of the Renin Angiotensin System (RAS) | 2015 |
Role of Collectrin, an ACE2 Homologue, in Blood Pressure Homeostasis
PL Chu, TH Le |
Current Hypertension Reports | 2014 |
Comprehensive Physiology
MA Sparks, SD Crowley, SB Gurley, M Mirotsou, TM Coffman |
Comprehensive Physiology | 2014 |
ACE2 deficiency increases NADPH-mediated oxidative stress in the kidney
J Wysocki, DI Ortiz-Melo, NK Mattocks, K Xu, J Prescott, K Evora, M Ye, MA Sparks, SK Haque, D Batlle, SB Gurley |
Physiological Reports | 2014 |
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
F Jiang, J Yang, Y Zhang, M Dong, S Wang, Q Zhang, FF Liu, K Zhang, C Zhang |
Nature Reviews Cardiology | 2014 |
ACE2: Angiotensin II/Angiotensin-(1–7) Balance in Cardiac and Renal Injury
J Varagic, S Ahmad, S Nagata, CM Ferrario |
Current Hypertension Reports | 2014 |
ACE in the hole
FC Luft |
Journal of Molecular Medicine | 2014 |
From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
SK Patel, E Velkoska, M Freeman, B Wai, TF Lancefield, LM Burrell |
Frontiers in physiology | 2014 |
The Application of Gaussian Mixture Models for Signal Quantification in MALDI-ToF Mass Spectrometry of Peptides
JC Spainhour, MG Janech, JH Schwacke, JC Velez, V Ramakrishnan, M Bader |
2014 | |
Generation of outbred Ace2 knockout mice by RNA transfection of TALENs displaying colitis reminiscent pathophysiology and inflammation
C Liu, L Xiao, F Li, H Zhang, Q Li, H Liu, S Fu, C Li, X Zhang, J Wang, NH Staunstrup, Y Li, H Yang |
Transgenic Research | 2014 |
Angiotensin-Converting Enzyme 2-Independent Action of Presumed Angiotensin-Converting Enzyme 2 Activators: Studies In Vivo, Ex Vivo, and In Vitro
PK Haber, M Ye, J Wysocki, C Maier, SK Haque, D Batlle |
Hypertension | 2014 |
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) IV: Circulating ACE2 as a Biomarker of Systolic Dysfunction in Human Hypertension and Heart Failure
K Úri, M Fagyas, IM Siket, A Kertész, Z Csanádi, G Sándorfi, M Clemens, R Fedor, Z Papp, I Édes, A Tóth, E Lizanecz, V Karamyan |
PloS one | 2014 |
Genetic modification of hypertension by sGCα1
PY Sips, ES Buys |
Trends in Cardiovascular Medicine | 2013 |
ACE2 alterations in kidney disease
MJ Soler, J Wysocki, D Batlle |
Nephrology Dialysis Transplantation | 2013 |
Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults
A Jovanovich, JH Ix, J Gottdiener, K McFann, R Katz, B Kestenbaum, IH de Boer, M Sarnak, MG Shlipak, KJ Mukamal, D Siscovick, M Chonchol |
Atherosclerosis | 2013 |
The association between the angiotensin-converting enzyme-2 gene and blood pressure in a cohort study of adolescents
L Malard, L Kakinami, J O’Loughlin, MH Roy-Gagnon, A Labbe, L Pilote, P Hamet, J Tremblay, G Paradis |
BMC Medical Genetics | 2013 |
Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry
N Grobe, NM Weir, O Leiva, FS Ong, KE Bernstein, AH Schmaier, M Morris, KM Elased |
American journal of physiology. Cell physiology | 2013 |
Regulation of urinary ACE2 in diabetic mice
J Wysocki, L Garcia-Halpin, M Ye, C Maier, K Sowers, KD Burns, D Batlle |
American journal of physiology. Renal physiology | 2013 |
ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition
T Perlot, JM Penninger |
Microbes and infection / Institut Pasteur | 2013 |
Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice
Emmanuel Buys, Michael Raher, Andrew Kirby, Shahid Mohd, David Baron, Sarah Hayton, Laurel Tainsh, Patrick Sips, Kristen Rauwerdink, Qingshang Yan, Robert Tainsh, Hannah Shakartzi, Christine Stevens, Kelly Decaluwe, Maria da Gloria Rodrigues-Machado, Rajeev Malhotra, Johan Van de Voorde, Tong Wang, Peter Brouckaert, Mark Daly, Kenneth Bloch |
Journal of Clinical Investigation | 2012 |
Recent Advances Involving the Renin-Angiotensin System
SD Crowley, TM Coffman |
Experimental Cell Research | 2012 |
Protective Role of the ACE2/Ang-(1–9) Axis in Cardiovascular Remodeling
MP Ocaranza, JE Jalil |
International Journal of Hypertension | 2012 |
New Cardiovascular and Pulmonary Therapeutic Strategies Based on the Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas Receptor Axis
AJ Ferreira, TM Murça, RA Fraga-Silva, CH Castro, MK Raizada, RA Santos |
International Journal of Hypertension | 2012 |
Deficiency of ACE2 in Bone-Marrow-Derived Cells Increases Expression of TNF-α in Adipose Stromal Cells and Augments Glucose Intolerance in Obese C57BL/6 Mice
SE Thatcher, M Gupte, N Hatch, LA Cassis |
International Journal of Hypertension | 2012 |
Will the real angiotensin converting enzyme please stand up?
FC Luft |
Journal of Molecular Medicine | 2012 |
Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease
C Tikellis, MC Thomas |
International Journal of Peptides | 2012 |
REGULATION AND FUNCTION OF THE FGF23/KLOTHO ENDOCRINE PATHWAYS
A Martin, V David, LD Quarles |
Physiological reviews | 2012 |
Angiotensin-Converting Enzyme 2: The First Decade
NE Clarke, AJ Turner |
International Journal of Hypertension | 2012 |
A Comparative Transcriptome Analysis Identifying FGF23 Regulated Genes in the Kidney of a Mouse CKD Model
B Dai, V David, A Martin, J Huang, H Li, Y Jiao, W Gu, LD Quarles |
PloS one | 2012 |
Brain renin-angiotensin system in the nexus of hypertension and aging
AC Arnold, PE Gallagher, DI Diz |
Hypertension Research | 2012 |
Adenoviral delivery of angiotensin-(1-7) or angiotensin-(1-9) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptor
M Flores-Muñoz, BM Godinho, A Almalik, SA Nicklin |
PloS one | 2012 |
Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney
N Grobe, KM Elased, DR Cool, M Morris |
American journal of physiology. Endocrinology and metabolism | 2012 |
Murine Recombinant Angiotensin-Converting Enzyme 2: Effect on Angiotensin II–Dependent Hypertension and Distinctive Angiotensin-Converting Enzyme 2 Inhibitor Characteristics on Rodent and Human Angiotensin-Converting Enzyme 2
M Ye, J Wysocki, FR Gonzalez-Pacheco, M Salem, K Evora, L Garcia-Halpin, M Poglitsch, M Schuster, D Batlle |
Hypertension | 2012 |
New Insights and Perspectives on Intrarenal Renin-Angiotensin System: Focus on Intracrine/Intracellular Angiotensin II*
JL Zhuo, XC Li |
Peptides | 2011 |
Role of ACE2 in diastolic and systolic heart failure
W Wang, S Bodiga, SK Das, J Lo, V Patel, GY Oudit |
Heart Failure Reviews | 2011 |
Recombinant Human Angiotensin-Converting Enzyme 2 as a New Renin-Angiotensin System Peptidase for Heart Failure Therapy
GY Oudit, JM Penninger |
Current Heart Failure Reports | 2011 |
Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays
KB Pedersen, S Sriramula, KH Chhabra, H Xia, E Lazartigues |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2011 |
ACE2-Mediated Reduction of Oxidative Stress in the Central Nervous System Is Associated with Improvement of Autonomic Function
H Xia, S Suda, S Bindom, Y Feng, SB Gurley, D Seth, LG Navar, E Lazartigues, MV Blagosklonny |
PloS one | 2011 |
Angiotensin-Converting Enzyme 2 Deficiency in Whole Body or Bone Marrow–Derived Cells Increases Atherosclerosis in Low-Density Lipoprotein Receptor −/− Mice
SE Thatcher, X Zhang, DA Howatt, H Lu, SB Gurley, A Daugherty, LA Cassis |
Arteriosclerosis, thrombosis, and vascular biology | 2011 |
Angiotensin-Converting Enzyme 2 Deficiency Is Associated With Impaired Gestational Weight Gain and Fetal Growth Restriction
MS Bharadwaj, WB Strawn, L Groban, LM Yamaleyeva, MC Chappell, C Horta, K Atkins, L Firmes, SB Gurley, KB Brosnihan |
Hypertension | 2011 |
AT 1 Receptors in the Collecting Duct Directly Modulate the Concentration of Urine
J Stegbauer, SB Gurley, MA Sparks, M Woznowski, DE Kohan, M Yan, RW Lehrich, TM Coffman |
Journal of the American Society of Nephrology : JASN | 2011 |
ACE2/ANG-(1–7)/Mas pathway in the brain: the axis of good
P Xu, S Sriramula, E Lazartigues |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2010 |
The Impact of Microsomal Prostaglandin E Synthase 1 on Blood Pressure Is Determined by Genetic Background
CS Facemire, R Griffiths, LP Audoly, BH Koller, TM Coffman |
Hypertension | 2010 |
The renin angiotensin system and the metabolic syndrome
CH Wang, F Li, N Takahashi |
The open hypertension journal | 2010 |
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases
L Shi, C Mao, Z Xu, L Zhang |
Drug Discovery Today | 2010 |
Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent
J Liu, H Ji, W Zheng, X Wu, JJ Zhu, AP Arnold, K Sandberg |
Biology of sex differences | 2010 |
Gene expression profiles linked to AT1 angiotensin receptors in the kidney
NA Makhanova, SD Crowley, RC Griffiths, TM Coffman |
Physiological genomics | 2010 |
Effects of ACE2 Inhibition in the Post-Myocardial Infarction Heart
MA Kim, D Yang, K Kida, N Molotkova, SJ Yeo, N Varki, M Iwata, ND Dalton, KL Peterson, WE Siems, T Walther, RT Cowling, J Kjekshus, B Greenberg |
Journal of Cardiac Failure | 2010 |
Inhibition of Angiotensin-Converting Enzyme 2 Exacerbates Cardiac Hypertrophy and Fibrosis in Ren-2 Hypertensive Rats
AJ Trask, L Groban, BM Westwood, J Varagic, D Ganten, PE Gallagher, MC Chappell, CM Ferrario |
American Journal of Hypertension | 2010 |
Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure
M Iwata, RT Cowling, SJ Yeo, B Greenberg |
Journal of Molecular and Cellular Cardiology | 2010 |
Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters
K Kuba, Y Imai, T Ohto-Nakanishi, JM Penninger |
Pharmacology & Therapeutics | 2010 |
Vascular Angiotensin-Converting Enzyme 2: Lord of the Ring?
D Batlle, J Wysocki, MS Khan |
Circulation research | 2010 |
Sex Chromosome Effects Unmasked in Angiotensin II–Induced Hypertension
H Ji, W Zheng, X Wu, J Liu, CM Ecelbarger, R Watkins, AP Arnold, K Sandberg |
Hypertension | 2010 |
Therapeutic Implications of the Vasoprotective Axis of the Renin-Angiotensin System in Cardiovascular Diseases
AJ Ferreira, RA Santos, CN Bradford, AP Mecca, C Sumners, MJ Katovich, MK Raizada |
Hypertension | 2010 |
Renin–angiotensin system in human coronavirus pathogenesis
BA Wevers, L van der Hoek |
Future Virology | 2010 |
Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension
J Wysocki, M Ye, E Rodriguez, FR González-Pacheco, C Barrios, K Evora, M Schuster, H Loibner, KB Brosnihan, CM Ferrario, JM Penninger, D Batlle |
Hypertension | 2009 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
The sweeter side of ACE2: Physiological evidence for a role in diabetes
SM Bindom, E Lazartigues |
Molecular and Cellular Endocrinology | 2009 |
Does ACE2 contribute to the development of hypertension?
MC Chappell |
Hypertension research : official journal of the Japanese Society of Hypertension | 2009 |
Not just angiotensinases: new roles for the angiotensin-converting enzymes
DW Lambert, NE Clarke, AJ Turner |
Cellular and Molecular Life Sciences | 2009 |
The role of ACE2 in pulmonary diseases--relevance for the nephrologist
GY Oudit, Y Imai, K Kuba, JW Scholey, JM Penninger |
Nephrology Dialysis Transplantation | 2009 |
Angiotensin-(1-7), Angiotensin-Converting Enzyme 2, and New Components of the Renin Angiotensin System
Trask AJ, Varagic J, Ahmad S, Ferrario CM |
2009 | |
AT2 receptors: Functional relevance in cardiovascular disease
ES Jones, A Vinh, CA McCarthy, TA Gaspari, RE Widdop |
Pharmacology & Therapeutics | 2008 |
Renin-angiotensin system revisited
F Fyhrquist, O Saijonmaa |
Journal of Internal Medicine | 2008 |
Are we poised to target ACE2 for the next generation of antihypertensives?
AJ Ferreira, MK Raizada |
Journal of Molecular Medicine | 2008 |
The importance of the intrarenal renin–angiotensin system
JC Velez |
Nature clinical practice. Nephrology | 2008 |
Angiotensin II Up-Regulates Angiotensin I-Converting Enzyme (ACE), but Down-Regulates ACE2 via the AT1-ERK/p38 MAP Kinase Pathway
V Koka, XR Huang, AC Chung, W Wang, LD Truong, HY Lan |
The American Journal of Pathology | 2008 |
ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet
M Gupte, CM Boustany-Kari, K Bharadwaj, S Police, S Thatcher, MC Gong, VL English, LA Cassis |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2008 |
Angiotensin-converting enzyme 2 in the brain: properties and future directions
H Xia, E Lazartigues |
Journal of Neurochemistry | 2008 |
The angiotensin converting enzyme 2/Ang-(1-7) axis in the heart: a role for MAS communication?
JA Stewart, E Lazartigues, PA Lucchesi |
Circulation research | 2008 |
MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides
PE Gallagher, CM Ferrario, EA Tallant |
American journal of physiology. Cell physiology | 2008 |
Enzima conversiva de la angiotensina 2 y su papel emergente en la regulación del sistema renina-angiotensina
MJ Soler, J Lloveras, D Batlle |
Medicina Clínica | 2008 |
Angiotensin-converting enzyme 2: Possible role in hypertension and kidney disease
J Wysocki, FR González-Pacheco, D Batlle |
Current Hypertension Reports | 2008 |
Thiol-based angiotensin-converting enzyme 2 inhibitors: P1′ modifications for the exploration of the S1′ subsite
DN Deaton, KP Graham, JW Gross, AB Miller |
Bioorganic & Medicinal Chemistry Letters | 2008 |
Angiotensin-converting enzyme 2 and new insights into the renin–angiotensin system
DW Lambert, NM Hooper, AJ Turner |
Biochemical Pharmacology | 2008 |
Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite
DN Deaton, EN Gao, KP Graham, JW Gross, AB Miller, JM Strelow |
Bioorganic & Medicinal Chemistry Letters | 2008 |
Renin-Angiotensin System - Considerations for Hypertension and Kidney
HE Yim, KH Yoo |
Electrolyte & blood pressure : E & BP | 2008 |
ANGIOTENSIN CONVERTING ENZYME 2 IN THE KIDNEY
A Koitka, ME Cooper, MC Thomas, C Tikellis |
Clinical and experimental pharmacology & physiology | 2008 |
Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury
DW Wong, GY Oudit, H Reich, Z Kassiri, J Zhou, QC Liu, PH Backx, JM Penninger, AM Herzenberg, JW Scholey |
The American Journal of Pathology | 2007 |
Is Angiotensin II a Direct Mediator of Left Ventricular Hypertrophy?: Time for Another Look
TL Reudelhuber, KE Bernstein, P Delafontaine |
Hypertension | 2007 |
The emerging role of ACE2 in physiology and disease
I Hamming, ME Cooper, BL Haagmans, NM Hooper, R Korstanje, AD Osterhaus, W Timens, AJ Turner, G Navis, H van Goor |
The Journal of Pathology | 2007 |
Local Angiotensin Generation and AT2 Receptor Activation
Esch JH, Danser AH |
2007 | |
ACE Inhibition in Heart Failure and Ischaemic Heart Disease
Campbell DJ |
2007 |